These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39004413)

  • 41. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.
    Bonaventura J; Gomez JL; Carlton ML; Lam S; Sanchez-Soto M; Morris PJ; Moaddel R; Kang HJ; Zanos P; Gould TD; Thomas CJ; Sibley DR; Zarate CA; Michaelides M
    Mol Psychiatry; 2022 Oct; 27(10):4144-4156. PubMed ID: 35768639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
    Aleksandrova LR; Wang YT; Phillips AG
    Mol Brain; 2020 Jun; 13(1):92. PubMed ID: 32546197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.
    Chowdhury GM; Zhang J; Thomas M; Banasr M; Ma X; Pittman B; Bristow L; Schaeffer E; Duman RS; Rothman DL; Behar KL; Sanacora G
    Mol Psychiatry; 2017 Jan; 22(1):120-126. PubMed ID: 27067013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.
    Wulf HA; Browne CA; Zarate CA; Lucki I
    Psychopharmacology (Berl); 2022 Jul; 239(7):2309-2316. PubMed ID: 35459958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinociceptive and Analgesic Effects of (2
    Yost JG; Wulf HA; Browne CA; Lucki I
    J Pharmacol Exp Ther; 2022 Sep; 382(3):256-265. PubMed ID: 35779947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of subanesthetic ketamine and (2R,6R) hydroxynorketamine on working memory and synaptic transmission in the nucleus reuniens in mice.
    Goswamee P; Rice R; Leggett E; Zhang F; Manicka S; Porter JH; McQuiston AR
    Neuropharmacology; 2022 May; 208():108965. PubMed ID: 35065945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
    Zarate CA; Brutsche N; Laje G; Luckenbaugh DA; Venkata SL; Ramamoorthy A; Moaddel R; Wainer IW
    Biol Psychiatry; 2012 Aug; 72(4):331-8. PubMed ID: 22516044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration.
    Zhou Z; Zhang G; Li X; Liu X; Wang N; Qiu L; Liu W; Zuo Z; Yang J
    Mol Neurobiol; 2015 Apr; 51(2):808-19. PubMed ID: 24973145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
    Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
    J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
    Hashimoto K
    Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.
    Highland JN; Zanos P; Riggs LM; Georgiou P; Clark SM; Morris PJ; Moaddel R; Thomas CJ; Zarate CA; Pereira EFR; Gould TD
    Pharmacol Rev; 2021 Apr; 73(2):763-791. PubMed ID: 33674359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
    Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
    Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
    Zanos P; Moaddel R; Morris PJ; Georgiou P; Fischell J; Elmer GI; Alkondon M; Yuan P; Pribut HJ; Singh NS; Dossou KS; Fang Y; Huang XP; Mayo CL; Wainer IW; Albuquerque EX; Thompson SM; Thomas CJ; Zarate CA; Gould TD
    Nature; 2016 May; 533(7604):481-6. PubMed ID: 27144355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
    Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
    Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
    Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
    J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.
    Gerhard DM; Pothula S; Liu RJ; Wu M; Li XY; Girgenti MJ; Taylor SR; Duman CH; Delpire E; Picciotto M; Wohleb ES; Duman RS
    J Clin Invest; 2020 Mar; 130(3):1336-1349. PubMed ID: 31743111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.
    Riggs LM; Aracava Y; Zanos P; Fischell J; Albuquerque EX; Pereira EFR; Thompson SM; Gould TD
    Neuropsychopharmacology; 2020 Jan; 45(2):426-436. PubMed ID: 31216563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice.
    Hillhouse TM; Partridge KJ; Garrett PI; Honeycutt SC; Porter JH
    PLoS One; 2024; 19(4):e0301848. PubMed ID: 38640139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.
    Fuchikami M; Thomas A; Liu R; Wohleb ES; Land BB; DiLeone RJ; Aghajanian GK; Duman RS
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8106-11. PubMed ID: 26056286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.